Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
10 01 2020
Historique:
received: 24 05 2018
revised: 20 03 2019
accepted: 14 11 2019
pubmed: 30 11 2019
medline: 19 5 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

Despite the importance of glucose and amino acids for energy metabolism, interactions between the two nutrients are not well understood. We provide evidence for a role of leucyl-tRNA synthetase 1 (LARS1) in glucose-dependent control of leucine usage. Upon glucose starvation, LARS1 was phosphorylated by Unc-51 like autophagy activating kinase 1 (ULK1) at the residues crucial for leucine binding. The phosphorylated LARS1 showed decreased leucine binding, which may inhibit protein synthesis and help save energy. Leucine that is not used for anabolic processes may be available for catabolic pathway energy generation. The LARS1-mediated changes in leucine utilization might help support cell survival under glucose deprivation. Thus, depending on glucose availability, LARS1 may help regulate whether leucine is used for protein synthesis or energy production.

Identifiants

pubmed: 31780625
pii: science.aau2753
doi: 10.1126/science.aau2753
doi:

Substances chimiques

Autophagy-Related Protein-1 Homolog EC 2.7.11.1
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Monomeric GTP-Binding Proteins EC 3.6.5.2
LARS protein, mouse EC 6.1.1.4
LARS1 protein, human EC 6.1.1.4
Leucine-tRNA Ligase EC 6.1.1.4
Leucine GMW67QNF9C
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-210

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Ina Yoon (I)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Miso Nam (M)

Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul 03759, Republic of Korea.

Hoi Kyoung Kim (HK)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Hee-Sun Moon (HS)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Sungmin Kim (S)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Jayun Jang (J)

Department of Molecular Medicine and Biopharmaceutical Sciences and Graduate School for Convergence Technologies, Seoul National University, Seoul 08826, Republic of Korea.

Ji Ae Song (JA)

Department of Molecular Medicine and Biopharmaceutical Sciences and Graduate School for Convergence Technologies, Seoul National University, Seoul 08826, Republic of Korea.

Seung Jae Jeong (SJ)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Sang Bum Kim (SB)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Seongmin Cho (S)

Department of Molecular Medicine and Biopharmaceutical Sciences and Graduate School for Convergence Technologies, Seoul National University, Seoul 08826, Republic of Korea.

YounHa Kim (Y)

Department of Molecular Medicine and Biopharmaceutical Sciences and Graduate School for Convergence Technologies, Seoul National University, Seoul 08826, Republic of Korea.

Jihye Lee (J)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Won Suk Yang (WS)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Hee Chan Yoo (HC)

Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.

Kibum Kim (K)

Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Department of Integrated OMICS for Biomedical Science, Yonsei University, Seoul 03722, Republic of Korea.

Min-Sun Kim (MS)

Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul 03759, Republic of Korea.

Aerin Yang (A)

Department of Chemistry, Korea Advanced Institute of Science and Technology, Yuseong-gu, Daejeon 34141, Republic of Korea.

Kyukwang Cho (K)

Department of Chemistry, Korea Advanced Institute of Science and Technology, Yuseong-gu, Daejeon 34141, Republic of Korea.

Hee-Sung Park (HS)

Department of Chemistry, Korea Advanced Institute of Science and Technology, Yuseong-gu, Daejeon 34141, Republic of Korea.

Geum-Sook Hwang (GS)

Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul 03759, Republic of Korea.

Kwang Yeon Hwang (KY)

Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seongbuk-gu, Seoul 02841, Republic of Korea.

Jung Min Han (JM)

Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea.
Department of Integrated OMICS for Biomedical Science, Yonsei University, Seoul 03722, Republic of Korea.

Jong Hyun Kim (JH)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea. kimjohn@biocon.snu.ac.kr sungkim@biocon.snu.ac.kr.

Sunghoon Kim (S)

Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea. kimjohn@biocon.snu.ac.kr sungkim@biocon.snu.ac.kr.
Department of Molecular Medicine and Biopharmaceutical Sciences and Graduate School for Convergence Technologies, Seoul National University, Seoul 08826, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH